AU2013290826B2 - Injectable antibiotic formulations and their methods of use - Google Patents

Injectable antibiotic formulations and their methods of use Download PDF

Info

Publication number
AU2013290826B2
AU2013290826B2 AU2013290826A AU2013290826A AU2013290826B2 AU 2013290826 B2 AU2013290826 B2 AU 2013290826B2 AU 2013290826 A AU2013290826 A AU 2013290826A AU 2013290826 A AU2013290826 A AU 2013290826A AU 2013290826 B2 AU2013290826 B2 AU 2013290826B2
Authority
AU
Australia
Prior art keywords
composition
pnt
penethamate
compositions
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013290826A
Other languages
English (en)
Other versions
AU2013290826A1 (en
Inventor
Fadil Al Alawi
Olaf Bork
Rohit Jain
Karthigeyan Nanjan
Ian George Tucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco New Zeeland
Original Assignee
Elanco New Zeeland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49949085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2013290826(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NZ613138A external-priority patent/NZ613138B2/en
Application filed by Elanco New Zeeland filed Critical Elanco New Zeeland
Publication of AU2013290826A1 publication Critical patent/AU2013290826A1/en
Application granted granted Critical
Publication of AU2013290826B2 publication Critical patent/AU2013290826B2/en
Assigned to Elanco New Zealand reassignment Elanco New Zealand Request for Assignment Assignors: BAYER NEW ZEALAND LIMITED
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2013290826A 2012-07-17 2013-07-16 Injectable antibiotic formulations and their methods of use Active AU2013290826B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NZ601299 2012-07-17
NZ60129912 2012-07-17
NZ61017513 2013-05-03
NZ610175 2013-05-03
NZ613138A NZ613138B2 (en) 2013-07-12 Injectable antibiotic formulations and their methods of use
NZ613138 2013-07-12
PCT/NZ2013/000123 WO2014014363A1 (en) 2012-07-17 2013-07-16 Injectable antibiotic formulations and their methods of use

Publications (2)

Publication Number Publication Date
AU2013290826A1 AU2013290826A1 (en) 2015-01-15
AU2013290826B2 true AU2013290826B2 (en) 2018-10-18

Family

ID=49949085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013290826A Active AU2013290826B2 (en) 2012-07-17 2013-07-16 Injectable antibiotic formulations and their methods of use

Country Status (30)

Country Link
US (1) US10376585B2 (enExample)
EP (1) EP2874624B8 (enExample)
JP (1) JP6189437B2 (enExample)
KR (1) KR102113822B1 (enExample)
CN (1) CN104470517B (enExample)
AU (1) AU2013290826B2 (enExample)
BR (1) BR112014031083B1 (enExample)
CA (1) CA2875351C (enExample)
CL (1) CL2014003423A1 (enExample)
CO (1) CO7240359A2 (enExample)
CR (1) CR20140550A (enExample)
DK (1) DK2874624T3 (enExample)
DO (1) DOP2014000288A (enExample)
ES (1) ES2752034T3 (enExample)
HR (1) HRP20191730T1 (enExample)
HU (1) HUE046427T2 (enExample)
IL (1) IL236713B (enExample)
LT (1) LT2874624T (enExample)
MX (2) MX387668B (enExample)
MY (1) MY172561A (enExample)
NI (1) NI201400152A (enExample)
PH (1) PH12014502716A1 (enExample)
PL (1) PL2874624T3 (enExample)
PT (1) PT2874624T (enExample)
RU (1) RU2643327C2 (enExample)
SI (1) SI2874624T1 (enExample)
SV (1) SV2014004882A (enExample)
UA (1) UA118654C2 (enExample)
WO (1) WO2014014363A1 (enExample)
ZA (1) ZA201409322B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014098624A1 (en) * 2012-12-20 2014-06-26 Alleva Animal Health Limited Veterinary injectable formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446144A (en) * 1979-05-21 1984-05-01 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Derivatives of penicillanic acid
CN1517090A (zh) * 2003-01-20 2004-08-04 王玉万 含抗菌药物的兽用混悬注射剂或乳剂
CN101822637A (zh) * 2009-12-31 2010-09-08 天津瑞普生物技术股份有限公司 一种含有β-内酰胺类抗生素的混悬注射剂

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
EP0115001B1 (de) 1982-12-28 1988-06-15 Bayer Ag Stabile Aminoglykosid-Penicillin-Injektionsformulierungen
US5736151A (en) 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
CH693625A5 (it) * 1999-02-18 2003-11-28 Inpharma Sa Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi.
US20040022815A1 (en) 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US6911441B2 (en) 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
US20050143347A1 (en) * 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
DE102004025324A1 (de) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
US20060142234A1 (en) 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US8679540B2 (en) * 2006-06-09 2014-03-25 Flamel Technologies Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
ES2716474T3 (es) * 2007-10-26 2019-06-12 Avivagen Inc Composiciones y métodos para mejorar la respuesta inmunitaria
PL2294012T3 (pl) * 2008-05-07 2014-12-31 Salix Pharmaceuticals Inc Podawanie środka czyszczącego jelito i antybiotyku w leczeniu choroby jelit
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
WO2010138918A1 (en) * 2009-05-29 2010-12-02 Pacira Pharmaceuticals, Inc. Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
US20110223208A1 (en) * 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
DE102010015143A1 (de) 2010-04-16 2011-10-20 Cts Chemical Industries Ltd. Stabile flüssige ölige gebrauchsfertige Formulierungen, Herstellung davon und Verwendung davon
MX355769B (es) * 2011-06-23 2018-04-30 Bayer New Zealand Ltd Una composición antiparasitaria y método de tratamiento.
WO2013095166A1 (en) 2011-12-23 2013-06-27 Bayer New Zealand Limited Antibiotic formulations
CN110604819A (zh) * 2012-02-27 2019-12-24 拜耳新西兰有限公司 控制释放组合物及其使用方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446144A (en) * 1979-05-21 1984-05-01 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Derivatives of penicillanic acid
CN1517090A (zh) * 2003-01-20 2004-08-04 王玉万 含抗菌药物的兽用混悬注射剂或乳剂
CN101822637A (zh) * 2009-12-31 2010-09-08 天津瑞普生物技术股份有限公司 一种含有β-内酰胺类抗生素的混悬注射剂

Also Published As

Publication number Publication date
WO2014014363A1 (en) 2014-01-23
PH12014502716B1 (en) 2015-02-02
KR20150036092A (ko) 2015-04-07
CA2875351C (en) 2021-08-31
IL236713A0 (en) 2015-02-26
CL2014003423A1 (es) 2015-04-17
LT2874624T (lt) 2019-12-10
BR112014031083B1 (pt) 2021-06-15
MX387668B (es) 2025-03-18
CN104470517A (zh) 2015-03-25
HRP20191730T1 (hr) 2019-12-13
MX358248B (es) 2018-08-10
CN104470517B (zh) 2018-12-18
UA118654C2 (uk) 2019-02-25
RU2643327C2 (ru) 2018-01-31
MX2014015927A (es) 2015-03-03
BR112014031083A2 (pt) 2017-06-27
IL236713B (en) 2018-05-31
NI201400152A (es) 2015-03-27
EP2874624A1 (en) 2015-05-27
ES2752034T3 (es) 2020-04-02
EP2874624B1 (en) 2019-08-21
DOP2014000288A (es) 2015-02-15
EP2874624B8 (en) 2019-10-02
AU2013290826A1 (en) 2015-01-15
MY172561A (en) 2019-12-03
CR20140550A (es) 2015-02-05
HUE046427T2 (hu) 2020-03-30
KR102113822B1 (ko) 2020-05-22
ZA201409322B (en) 2015-12-23
DK2874624T3 (da) 2019-11-11
JP6189437B2 (ja) 2017-08-30
CO7240359A2 (es) 2015-04-17
RU2015105251A (ru) 2016-09-10
SI2874624T1 (sl) 2020-02-28
SV2014004882A (es) 2016-11-11
JP2015522608A (ja) 2015-08-06
CA2875351A1 (en) 2014-01-23
PH12014502716A1 (en) 2015-02-02
EP2874624A4 (en) 2015-12-02
US10376585B2 (en) 2019-08-13
PL2874624T3 (pl) 2020-07-27
PT2874624T (pt) 2019-11-04
US20150174248A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
AU2016200509B2 (en) Compositions comprising buprenorphine
RU2627429C2 (ru) Составы с контролируемым высвобождением и способы их использования
AU2013290826B2 (en) Injectable antibiotic formulations and their methods of use
US20040022815A1 (en) Novel pharmaceutical composition of ceftiofur
US9452155B2 (en) Injectable antibiotic formulations and their methods of use
NZ613138A (en) Injectable antibiotic formulations and their methods of use
NZ613138B2 (en) Injectable antibiotic formulations and their methods of use
TWI631948B (zh) 可注射型抗生素配方及其使用方法
NZ613240B2 (en) Injectable antibiotic formulations and their methods of use
EP2934524B1 (en) Penethamate veterinary injectable formulations
WO2024127418A1 (en) Injectable compositions of posaconazole
WO2024224424A1 (en) Injectable compositions of metolazone
WO2023148763A1 (en) Injectable pharmaceutical compositions of azole antifungal agents
NZ619101B2 (en) Veterinary Injectable Formulations
AU2013364500A1 (en) Veterinary injectable formulations
Simsek PARENTERAL SUSPENSION: AN OVERVIEW
NZ607636B2 (en) Controlled Release Compositions and Their Methods of Use

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: ELANCO NEW ZEALAND

Free format text: FORMER OWNER(S): BAYER NEW ZEALAND LIMITED